Anti-proliferative, c-Met Inhibitions, and PAINS Evaluations of New Thiophene, Thiazole, Coumarin, Pyran, and Pyridine Derivatives

被引:2
|
作者
Mohareb, Rafat M. [1 ]
Abdo, Nadia Y. Megally [2 ]
Ibrahim, Rehab A. [3 ]
Samir, Eman M. [4 ]
机构
[1] Cairo Univ, Fac Sci, Dept Chem, Cairo, Egypt
[2] Alexandria Univ, Fac Educ, Dept Chem, Alexandria 21526, Egypt
[3] Higher Inst Engn & Technol, New Cairo, Egypt
[4] Egyptian Drug Author EDA NODCAR, PO 29, Cairo, Egypt
关键词
Cyclohexane-1; 3-dione; thiazole; coumarin; pyran; pyridine; anti-proliferative; SOLVENT-FREE SYNTHESIS; 1,3-DICARBONYL COMPOUNDS; ANTIINFLAMMATORY ACTIVITIES; BIOLOGICAL-ACTIVITIES; 3-COMPONENT REACTION; MICHAEL ADDITION; CATALYST; CYTOTOXICITY; DISCOVERY; PYRAZOLE;
D O I
10.2174/1871520621666211103104408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: 1,3-Diones are versatile reagents used for many heterocyclic transformations. Among such groups of compounds, cyclohexane-1,3-dione is widely used in organic synthesis to produce biologically active compounds. Objective: In this work, target molecules were synthesized from tetrahydrobenzo[b]thiophen-3- carboxamide derivative with different substituents, and their structure-activity relationships were discussed in detail. Methods: Cyclohexane-1,3-dione underwent different multi-component reactions to produce fused thiophene, thiazole, coumarin, pyran, and pyridine derivatives. The anti-proliferative activity of the newly synthesized compounds toward the six cancer cell lines, namely A549, H460, HT-29, MKN-45, U87MG, and SMMC-7721 was studied. In addition, inhibitions of the most active compounds toward cancer cell lines classified according to the disease were also studied. Furthermore, Pan Assay Interference compounds (PAINS) of the selected compounds were analyzed, along with the c-Met inhibitions. Results: Anti-proliferative evaluations were performed for all of the synthesized compounds, in which the varieties of substituents through the aryl ring and the heterocyclic ring afforded compounds with high activities. Inhibition activity against the cancer cell lines classified according to the disease, c-Met, and PAINS of the synthesized compounds were measured. Conclusion: Compounds 3, 13a, 13b, 14a, 16f, 17a, 28, 30a, and 31 were the most cytotoxic compounds toward the six cancer cell lines. Inhibition toward cancer cell lines classified according to the disease showed that, in most cases, the presence of the electronegative CN and or Cl groups within the molecule was responsible for its high activity.
引用
收藏
页码:2125 / 2141
页数:17
相关论文
共 43 条
  • [31] Synthesis and evaluation of novel 4H-pyrazole and thiophene derivatives derived from chalcone as potential anti-proliferative agents, Pim-1 kinase inhibitors, and PAINS
    Megally Abdo, Nadia Y.
    Samir, Eman M.
    Mohareb, Rafat M.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2020, 57 (04) : 1993 - 2009
  • [32] Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity
    Abdel-Rahman, Adel A-H
    Shaban, Amira K. F.
    Nassar, Ibrahim F.
    EL-Kady, Dina S.
    Ismail, Nasser S. M.
    Mahmoud, Samy F.
    Awad, Hanem M.
    El-Sayed, Wael A.
    MOLECULES, 2021, 26 (13):
  • [33] Synthesis of Pyridine and Spiropyridine Derivatives Derived from 2-aminoprop-1-ene-1,1,3-tricarbonitrile Together with their c-Met Kinase and Antiproliferative Evaluations
    Mohareb, Rafat M.
    Abouzied, Amr S.
    Abbas, Nermeen S.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (14) : 1951 - 1962
  • [34] Synthesis and biological evaluation of new [1,2,4]triazolo[4,3-a]pyridine derivatives as potential c-Met inhibitors
    Zhao, Junjun
    Fang, Lei
    Zhang, Xiaobing
    Liang, Yan
    Gou, Shaohua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3483 - 3493
  • [35] Evaluation of the anti-proliferative activity of 2-oxo-pyridine and 1'H-spiro-pyridine derivatives as a new class of EGFRWt and VEGFR-2 inhibitors with apoptotic inducers
    Raslan, Reham R.
    Ammar, Yousry A.
    Fouad, Sawsan A.
    Hessein, Sadia A.
    Shmiess, Nadia A. M.
    Ragab, Ahmed
    RSC ADVANCES, 2023, 13 (15) : 10440 - 10458
  • [36] Cytotoxic activity of 3-nitropyrazolo[5,1-c][12,4]benzotriazine derivatives:: a new series of anti-proliferative agents
    Coronnello, M
    Ciciani, G
    Mini, E
    Guerrini, G
    Caciagli, B
    Selleri, S
    Costanzo, A
    Mazzei, T
    ANTI-CANCER DRUGS, 2005, 16 (06) : 645 - 651
  • [37] Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studies
    Elsebaie, Heba A.
    Nafie, Mohamed S.
    Tawfik, Haytham O.
    Belal, Amany
    Ghoneim, Mohammed M.
    Obaidullah, Ahmad J.
    Shaaban, Salwa
    Ayed, Abdelmoneim A.
    El-Naggar, Mohamed
    Mehany, Ahmed B. M.
    Shaldam, Moataz A.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (07): : 2553 - 2569
  • [38] Synthesis and Biological Evaluation of Novel 4,5,6,7-Tetrahydrobenzo[D]-Thiazol-2-Yl Derivatives Derived from Dimedone with Anti-Tumor, c-Met, Tyrosine Kinase and Pim-1 Inhibitions
    Mohareb, Rafat M.
    Abouzied, Amr S.
    Abbas, Nermeen S.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (12) : 1438 - 1453
  • [39] New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies
    Fadaly, Wael A. A.
    Zidan, Taha H.
    Kahk, Nesma M.
    Mohamed, Fatma E. A.
    Abdelhakeem, Marwa M.
    Khalil, Rehab G.
    Nemr, Mohamed T. M.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [40] Novel Pyrano[2,3-d]thiazole and Thiazolo[4,5-b]pyridine Derivatives: One-pot Three-component Synthesis and Biological Evaluation as Anticancer Agents, c-Met, and Pim-1 Kinase Inhibitors
    Abdallah, Amira E. M.
    Mohareb, Rafat M.
    Ahmed, Ebtsam A.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2019, 56 (11) : 3017 - 3029